Security Snapshot

Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) Institutional Ownership

CUSIP: 68062P106

13F Institutional Holders and Ownership History from Q4 2020 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

183

Shares (Excl. Options)

101.92MFull value: 101,921,779 · shares · 30 Jun 2026

Price

$12.51

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, par value $0.0001 per share
Symbol
OLMA on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
101,921,779
Latest holder snapshot 5 signals
Total 13F value
$1,275,247,437
Portfolio coverage rank
0%
Share change
+415,639
Value change
-$14,815,552
Number of holders
183
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
91,221,745
SEC-reported price per share
$7.92
Insider filing price
$7.92
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • OLMA - Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 68062P106.
  • 183 institutions reported positions in Q2 2026.
  • 9 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 193 to 183 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $1.51BFull value: $1,511,791,691 · USD · 31 Mar 2026
    to
    $1.28BFull value: $1,275,247,437 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 183 institutions filings for Q2 2026.

Open SEC evidence

Security key

68062P106

13F reference period

Q2 2026

13F holders

183

13D/G owners

9

CIK / CUSIP context first

Open Q2 2026 holders OLMA full holder history Olema Pharmaceuticals, Inc. SEC filings Olema Pharmaceuticals, Inc. company facts Olema Pharmaceuticals, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
9
Security
OLMA
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 14% +10% $143,813,985 +$24,737,094 12,075,062 +21% FMR LLC 30 Jun 2026
BIOTECHNOLOGY VALUE FUND L P 9.8% $77,238,382 8,939,731 BVF PARTNERS L P/IL 14 Oct 2026
Bain Capital Life Sciences Opportunities IV, L.P. 8.2% -18% $111,425,979 -$15,437,859 7,473,238 -12% Bain Capital Life Sciences Opportunities IV, L.P. 31 Mar 2026
Paradigm Biocapital Advisors LP 10% $37,443,949 7,429,355 Paradigm BioCapital Advisors LP 31 Dec 2024
JANUS HENDERSON GROUP PLC 8.2% -2.5% $105,987,556 +$5,938,564 7,108,488 +5.9% JANUS HENDERSON GROUP PLC 31 Mar 2026
BlackRock, Inc. 7.1% $78,115,092 6,244,212 BlackRock, Inc. 30 Jun 2026
Invus Global Management, LLC 5.1% $108,693,078 4,461,949 Raymond Debbane 16 Mar 2026
Logos Global Management LP 4.7% $16,172,730 3,208,875 Logos Global Management LP 18 Mar 2025
Point72 Asset Management, L.P. 2.3% $7,781,412 1,543,931 Point72 Asset Management, L.P. 31 Mar 2025
As of 30 Jun 2026, 183 institutional investors reported holding
101.92MFull value: 101,921,779 · shares · 30 Jun 2026
shares of Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA). This represents 112% of the company’s total
91.22MFull value: 91,221,745 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
93%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 13% 12,143,062 +17% 0.01% $151,909,702
Paradigm Biocapital Advisors LP 9.5% 8,670,576 +8.1% 2% $108,468,906
Jupiter Topco LLC 7.8% 7,094,413 0% 0.04% $88,802,842
Bain Capital Life Sciences Investors, LLC 7.8% 7,085,249 -5.2% 5.3% $88,636,465
BlackRock, Inc. 7.4% 6,714,691 +19% 0% $84,000,783
BVF INC/IL 5.8% 5,295,893 0% 1.7% $66,251,621
Siren, L.L.C. 5.3% 4,856,949 +2.1% 1.2% $60,760,432
STATE STREET CORP 4.7% 4,316,058 +9.6% 0% $53,993,886
VANGUARD CAPITAL MANAGEMENT LLC 3.7% 3,341,217 +8.4% 0% $41,798,625
Logos Global Management LP 3.5% 3,208,875 0% 1.7% $40,143,026
FRANKLIN RESOURCES INC 2.6% 2,349,586 +93% 0.01% $29,393,321
Cormorant Asset Management, LP 2.4% 2,150,000 -45% 1.4% $26,896,500
MORGAN STANLEY 2% 1,832,269 +51% 0% $22,921,685
GEODE CAPITAL MANAGEMENT, LLC 2% 1,819,029 +18% 0% $22,759,853
VANGUARD PORTFOLIO MANAGEMENT LLC 1.8% 1,663,218 +180% 0% $20,806,857
GOLDMAN SACHS GROUP INC 1.7% 1,567,979 +50% 0% $19,615,417
Deep Track Capital, LP 1.6% 1,500,000 0.28% $18,765,000
DIMENSIONAL FUND ADVISORS LP 1.6% 1,416,533 +31% 0% $17,718,405
LIGHTSPEED MANAGEMENT COMPANY, L.L.C. 1.5% 1,355,299 0% 0.71% $16,954,790
KINGDON CAPITAL MANAGEMENT, L.L.C. 1.3% 1,200,000 +40% 2% $15,012,000
TWO SIGMA INVESTMENTS, LP 1.2% 1,131,434 -3.2% 0.01% $14,154,239
Point72 Asset Management, L.P. 1.2% 1,070,949 +1406% 0.02% $13,397,572
Duquesne Family Office LLC 1.1% 986,827 0% 0.28% $12,345,000
Defilade Capital Management, L.P. 1% 924,758 -39% 1.5% $11,568,723
AMERIPRISE FINANCIAL INC 0.92% 840,646 +1366% 0% $10,516,481

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
24
Headline period
Q2 2026
Rows shown
1-24 of 24
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 767,717 $6,631,480 -$1,075,628 $8.64 24
2026 Q2 101,921,779 $1,275,247,437 -$14,815,552 $12.51 183
2026 Q1 101,411,965 $1,511,791,691 +$99,305,974 $14.91 193
2025 Q4 90,695,275 $2,267,572,776 +$591,383,435 $25.00 198
2025 Q3 68,238,531 $668,036,044 -$3,229,086 $9.79 124
2025 Q2 70,511,948 $300,429,144 +$22,565,282 $4.26 120
2025 Q1 65,888,228 $247,927,417 -$30,654,965 $3.76 131
2024 Q4 71,278,859 $415,382,388 +$48,509,843 $5.83 154
2024 Q3 58,658,581 $700,332,942 +$12,555,131 $11.94 129
2024 Q2 57,896,539 $626,445,097 +$18,080,243 $10.82 127
2024 Q1 56,110,675 $635,162,151 +$37,635,929 $11.32 125
2023 Q4 51,618,204 $717,066,039 +$56,526,765 $14.03 113
2023 Q3 47,322,813 $584,436,985 +$135,063,720 $12.35 97
2023 Q2 36,408,086 $328,764,561 +$43,216,272 $9.03 86
2023 Q1 33,447,196 $116,103,891 +$1,469,913 $3.47 65
2022 Q4 33,334,567 $81,640,055 -$481,138 $2.45 66
2022 Q3 33,359,693 $92,063,140 -$4,143,577 $2.76 67
2022 Q2 34,202,982 $139,234,855 -$8,391,103 $4.07 70
2022 Q1 36,374,849 $155,206,361 -$17,958,891 $4.26 86
2021 Q4 38,428,075 $359,510,482 -$41,441,250 $9.36 94
2021 Q3 36,741,334 $1,012,524,920 -$19,680,898 $27.56 75
2021 Q2 37,428,321 $1,047,268,923 +$59,576,299 $27.98 68
2021 Q1 35,240,926 $1,158,274,244 -$1,710,105 $33.18 73
2020 Q4 35,073,865 $1,657,230,008 +$1,657,206,010 $48.08 56
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .